Growth Metrics

Ocugen (OCGN) Free Cash Flow Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 60.84%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 88.70%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -15.72%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 66.37%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 3.98%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 137.65%
10 Ocugen 452.01 Mn 452.01 Mn - -12.53%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -12.53%
Dec 31, 2025 -36.14%
Sep 30, 2025 -9.31%
Jun 30, 2025 13.16%
Mar 31, 2025 -76.66%
Dec 31, 2024 26.01%
Sep 30, 2024 31.00%
Jun 30, 2024 42.52%
Mar 31, 2024 44.76%
Dec 31, 2023 8.89%
Sep 30, 2023 -5.09%
Jun 30, 2023 -57.81%
Mar 31, 2023 -26.63%
Dec 31, 2022 -18.44%
Sep 30, 2022 -96.28%
Jun 30, 2022 38.01%
Mar 31, 2022 -182.77%
Dec 31, 2021 -186.63%
Sep 30, 2021 -205.50%
Jun 30, 2021 -614.74%
Mar 31, 2021 -18.31%
Dec 31, 2020 48.13%
Sep 30, 2020 -27.88%
Jun 30, 2020 7.99%
Mar 31, 2020 -74.99%
Dec 31, 2019 -213.76%
Sep 30, 2019 65.50%
Jun 30, 2019 35.00%
Mar 31, 2019 -212.47%
Dec 31, 2018 37.57%
Sep 30, 2018 -6.17%
Jun 30, 2018 8.91%
Mar 31, 2018 132.25%
Dec 31, 2017 24.30%
Sep 30, 2017 -5.90%
Jun 30, 2017 16.97%
Mar 31, 2017 6.24%
Dec 31, 2016 17.28%
Sep 30, 2016 25.99%
Jun 30, 2016 13.29%
Mar 31, 2016 18.02%
Dec 31, 2015 -10.99%
Sep 30, 2015 -76.60%
Jun 30, 2015 -42.62%
Mar 31, 2015 -86.88%